These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 34519602)
1. Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug. Li W; Chen Z; Liu X; Lian M; Peng H; Zhang C Drug Deliv; 2021 Dec; 28(1):1903-1914. PubMed ID: 34519602 [TBL] [Abstract][Full Text] [Related]
2. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy. He W; Du Y; Zhou W; Wang T; Li M; Li X Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069 [TBL] [Abstract][Full Text] [Related]
3. A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination Chemotherapy. Hou C; Ma N; Shen Z; Chi G; Chao S; Pei Y; Chen L; Lu Y; Pei Z Int J Nanomedicine; 2020; 15():10417-10424. PubMed ID: 33376329 [TBL] [Abstract][Full Text] [Related]
4. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System. Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug. Xu Z; Zheng W; Yin Z Arch Pharm (Weinheim); 2014 Apr; 347(4):240-6. PubMed ID: 24402828 [TBL] [Abstract][Full Text] [Related]
6. Stimulus-Responsive Nano-Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery. Chu B; Deng H; Niu T; Qu Y; Qian Z Small Methods; 2024 Aug; 8(8):e2301271. PubMed ID: 38085682 [TBL] [Abstract][Full Text] [Related]
7. Drug Release from Disulfide-Linked Prodrugs: Role of Thiol Agents. Lei J; Zhang Q; Jin X; Lu H; Wang S; Li T; Sheng Y; Zhang F; Zheng Y Mol Pharm; 2021 Jul; 18(7):2777-2785. PubMed ID: 34121410 [TBL] [Abstract][Full Text] [Related]
8. High Drug Loading, Reversible Disulfide Core-Cross-Linked Multifunctional Micelles for Triggered Release of Camptothecin. Ling L; Ismail M; Du Y; Xia Q; He W; Yao C; Li X Mol Pharm; 2018 Dec; 15(12):5479-5492. PubMed ID: 30376635 [TBL] [Abstract][Full Text] [Related]
9. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy. Zhang F; Zhu G; Jacobson O; Liu Y; Chen K; Yu G; Ni Q; Fan J; Yang Z; Xu F; Fu X; Wang Z; Ma Y; Niu G; Zhao X; Chen X ACS Nano; 2017 Sep; 11(9):8838-8848. PubMed ID: 28858467 [TBL] [Abstract][Full Text] [Related]
10. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing. Ao M; Yu F; Li Y; Zhong M; Tang Y; Yang H; Wu X; Zhuang Y; Wang H; Sun X; Hong X; Chen XD J Nanobiotechnology; 2021 Oct; 19(1):350. PubMed ID: 34717646 [TBL] [Abstract][Full Text] [Related]
11. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug. He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480 [TBL] [Abstract][Full Text] [Related]
13. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy. He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266 [TBL] [Abstract][Full Text] [Related]
14. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery. Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750 [TBL] [Abstract][Full Text] [Related]
15. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency. Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396 [TBL] [Abstract][Full Text] [Related]
16. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy. Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058 [TBL] [Abstract][Full Text] [Related]
17. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release. Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423 [TBL] [Abstract][Full Text] [Related]
18. Poly(ethylene glycol) shell-sheddable nanomicelle prodrug of camptothecin with enhanced cellular uptake. Wu Q; Du F; Luo Y; Lu W; Huang J; Yu J; Liu S Colloids Surf B Biointerfaces; 2013 May; 105():294-302. PubMed ID: 23384692 [TBL] [Abstract][Full Text] [Related]
19. pH-sensitive prodrug conjugated polydopamine for NIR-triggered synergistic chemo-photothermal therapy. Zhang H; Sun Y; Huang R; Cang H; Cai Z; Sun B Eur J Pharm Biopharm; 2018 Jul; 128():260-271. PubMed ID: 29733952 [TBL] [Abstract][Full Text] [Related]
20. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery. Qu Y; Chu B; Wei X; Lei M; Hu D; Zha R; Zhong L; Wang M; Wang F; Qian Z J Control Release; 2019 Feb; 296():93-106. PubMed ID: 30664976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]